Can damaged or degenerated vessels be regenerated in the ear? The question is clinically important, as disruption of cochlear blood flow is seen in a wide variety of hearing disorders, including in loud soundinduced hearing loss (endothelial injury), ageing-related hearing loss (lost vascular density), and genetic hearing loss (e.g., Norrie disease: strial avascularization). Progression in cochlear blood flow (CBF) pathology can parallel progression in hair cell and hearing loss. However, neither new vessel growth in the ear, nor the role of angiogenesis in hearing, have been investigated. In this study, we used an established ex vivo tissue explant model in conjunction with a matrigel matrix model to demonstrate for the first time that new vessels can be generated by activating a vascular endothelial growth factor (VEGF-A) signal. Most intriguingly, we found that the pattern of the newly formed vessels resembles the natural 'mesh pattern' of in situ strial vessels, with both lumen and expression of tight junctions. Sphigosine-1-phosphate (S1P) in synergy with VEGF-A control new vessel size and growth. Using transgenic neural/glial antigen 2 (NG2) fluorescent reporter mice, we have furthermore discovered that the progenitors of "de novo" strial vessels are NG2-derived cells. Taken together, our data demonstrates that damaged strial microvessels can be regenerated by reprogramming NG2-derived angiogenic cells.
Introduction
Normal cochlear blood flow is critical for hearing. To sustain hearing acuity, a normal ion flow and nutrient balance must be maintained. The blood supply to the ear not only supplies energy to the neural tissue, it also is a source of hormones and neurotrophic factors for maintaining cochlear function and improving wound healing. This is particularly true since generation of the endocochlear potential (EP), an essential driving force for hair cell transduction (Salt et al., 1987) , is so metabolically demanding.
Likewise, it is reasonable to surmise restoration of hearing function after damage or loss of sensory cells would also require restoration or maintenance of an efficient blood supply. Despite this, the role of angiogenesis in the inner ear, particularly its role in hearing, has not been studied. Can damaged or degenerated vessels be regenerated in the ear? Recently, our lab discovered a rich population of neural glial antigen 2 (NG2+)/vimentin+/nestin+ perivascular cells (mesenchymal stem cells) harbored in the strial capillary network (unpublished data). The natural question was whether these cells have angiogenic potential and serve as vascular progenitors in angiogenesis. Angiogenesis is regulated by several different signaling pathways. A large number of studies have shown activation of vascular endothelial growth factor (VEGF)/VEGF-receptor (VEGFR) signaling central for angiogenesis, particularly under hypoxic or ischemic conditions (Dzietko et al., 2013) . The VEGF family in mammals comprises four members:
VEGF-A, VEGF-B, VEGF-C, and VEGF-D. VEGF-A stimulates angiogenesis via VEGF receptor 2 (VEGFR2) by inducing tip cell formation (Potente et al., 2011) . Therapeutic activation of the VEGF-A signal is commonly used for clinical treatment of myocardial ischemia and retinal disease (Bulysheva et al., 2016; Forsythe et al., 1996) . In this study, we investigated the role of the VEGF-A signaling since VEGF-A showed higher mRNA expression than other isoforms in our primary endothelial cell line.
In addition, several labs have found VEGF-A receptor expressed in strial vessels (Picciotti et al., 2006) .
But the question remained whether activation of VEGF-A signaling initiates angiogenesis in adult cochlea. To answer this question, we used an ex vivo strial vascular explant in combination with a threedimensional matrigel® angiogenesis model to study whether activation of VEGF-A signaling induces angiogenesis. We also identified the progenitors of the "new" vascular cells using transgenic fluorescent reporter mice under the control of an NG2 (Cspg4) promoter (all NG2-derived cells are fluorescence labeled). We found that new vessels can be generated from adult mouse cochlea by activating VEGF-A signaling in vitro, and that the newly formed vessels originate from the NG2-lineage mural cells.
Moreover, in this study, we also investigated the role of sphingosine-1-phosphate (S1P) signaling in strial angiogenesis. S1P is a bioactive lipid, involved in regulation of diverse functions, including immune system function, cell growth, angiogenesis, and vascular permeability (Mizugishi et al., 2005; Rosen et al., 2005; Skoura et al., 2009; Spiegel et al., 2003; Yatomi, 2006) . S1P is required for normal hearing M A N U S C R I P T
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function (Chen et al., 2014; MacLennan et al., 2006) . In particular, it was recently reported that defect in either S1P transporters or S1P receptors leads to EP loss and non-syndromic hearing loss, with the primary cause of strial vascular pathology (Ingham et al., 2016; Kono et al., 2007) . Thus our interest in the role that S1P plays in new strial vessel formation. Our results show S1P signaling significantly involved in cochlear angiogenesis, including in control of increased branch number and branch length.
Collectively, the findings from this study may lead to improved therapies for preventing sensory hair cell loss due to hypoxia caused by inefficient blood flow under various pathological conditions in the cochlea.
Materials and Methods

Animals
All strains of mice used in this study were purchased from the Jackson Laboratory, including the C57BL/6 
Primary cell lines
The mouse primary endothelial cell lines were generated from 10-to 15-day-old C57BL/6J mouse cochlea by a well-established 'mini-chip' protocol previously described and published (Neng et al., 2013) .
Endothelial cell proliferation and tube formation
To determine the effect of VEGF-A on endothelial cell proliferation, purified endothelial cells at 3.0 × 10 5 cells/ml were plated into 96-well flat clear bottom polystyrene tissue-culture treated microplates and allowed to adhere for 2 hrs. The plates were transferred into an IncuCyte ZOOM® platform housed in a cell incubator at 37°C/5% CO 2 . VEGF-A 165 , a soluble isoform of VEGF-A, at a concentration of 0 ng/ml, 10 ng/ml, 20 ng/ml, and 30 ng/ml was added to the CS-C medium (Sigma, USA). Cells were incubated for 120 hours. Medium was changed every two days. Two images per well from two technical replicates M A N U S C R I P T
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were taken every 10 min for 1 hour using a 20× objective lens. Cell proliferation was analyzed using The number of branch and branch points in each confocal field (1230 µm × 1230 µm) was quantified in 8 regions per group using Image J (NIH).
Ex vivo tissue explant and angiogenesis
For the ex vivo tissue explant, the stria vascularis was isolated from the spiral ligament, trimmed and cut into 2-3 mm pieces, embedded in a 3D matrigel® matrix (354234, Corning), and bathed in a growth factor containing culture media, as shown in Figure 1A . Either VEGF-A 165 at a final concentration of 50 ng/ml or S1P at a final concentration of 500 nM was added to each well of the plate with strial explants.
The culture medium was changed every two days to ensure constant agent concentration in the medium.
New vessel growth was recorded every day for 5 days under DIC and confocal fluorescence microscopy.
The rationale for terminating the experiment at 5 days is based on our initial observation that significant angiogenesis occurs by day 5. After day 5, the matrigel no longer provides enough matrix support and new vessels quickly regress. On the last day of the experiment, the strial tissue samples are fixed. 
Immunohistochemistry and fluorescence microscopy
The cochleae were isolated, harvested, and fixed in 4 % paraformaldehyde overnight at 4 °C, and rinsed in 37 °C phosphate-buffered saline (PBS; pH 7.2) to remove any residual 4 % paraformaldehyde. The stria vascularis was carefully isolated from the cochlear lateral wall. Strial tissues were permeabilized in 0.5 % Triton X-100 (Sigma, St. Louis, MO, USA) for 0.5 h and immunoblocked with a solution of 10 % goat serum and 1 % bovine serum albumin in 0.02 mol PBS for an additional hour. The specimens were incubated overnight at 4 °C with the primary antibody for PDGFR-β (Cat# ab32570, Abcam, 1:100) in PBS-bovine serum albumin. After three washes in PBS, the samples were incubated with secondary antibody, Alexa Fluor 568-conjugated goat anti-rabbit (Cat# A-11079, Life Technologies, at 1:200) for 1 h at room temperature. After three washes in PBS, the tissues were mounted in mounting medium (H-1000; Vector Laboratories, Inc., Burlingame, CA, USA) and visualized under an FV1000 Olympus laserscanning confocal microscope. Controls were prepared by replacing primary antibodies with PBS.
Transmission electron microscopy (TEM)
The strial explants were fixed overnight in phosphate-buffered 3% glutaraldehyde-1.5%
paraformaldehyde and post-fixed in 1% osmium. Strial tissues were dehydrated through a graded alcohol series and embedded in Embed 812 (Electron Microscopy Sciences, Hatfield, PA), sectioned, stained with lead citrate (Electron Microscopy Sciences, Hatfield, PA) and uranyl acetate (Electron Microscopy Sciences, Hatfield, PA), and viewed on a Philips EM 100 transmission electron microscope (Philips/FEI Corporation, Eindhoven, Holland).
Statistics
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Data were presented as means ± S.D. and were compared using Student's t-test for two groups or oneway ANOVA for three or more groups. P < 0.05 was considered statistically significant. GraphPad Prism 6.0 software was used for the statistical analysis.
Results
VEGF-A 165 promotes proliferation of endothelial cells and tube formation
VEGF-A, a pivotal growth factor, affects different cell types and has a wide spectrum of action on cell proliferation, migration, and differentiation, all critical for vascular development and restoration (Dzietko et al., 2013; Guo et al., 2016; Tashiro et al., 2014) . In this study, we used VEGF-A 165 , a soluble isoform of VEGF-A, used in conjunction with an IncuCyte® zoom system, to first investigate its effect on endothelial cell proliferation in an in vitro cell line model. We found that VEGF-A 165 promotes EC proliferation in a dose-dependent manner ( Figure 2A ). We also investigated the effect of VEGF-A 165 on endothelial tube formation in a 3D matrigel® matrix model. We found that VEGF-A 165 initiates significant endothelial tube formation when the endothelial cells are seeded in the 3D matrigel® matrix for 6 hours. 
VEGF-A 165 initiates a significant amount of new vessel growth in the stria vascularis by day 5
The microvessels in the stria vascularis provide 80% of the blood supply to the cochlea and control exchanges in the interstitial space of the cochlear lateral wall (Angelborg et al., 1984) , essential for the endocochlear potential and hearing function (Shi, 2016) . In this study, we investigated whether vessels in the stria vacularis can be regenerated by activation of the VEGF-A signal. We obtained strial explants from adult mouse (4 -8 week old) cochlea and embedded tissue explants in a 3D matrigel® matrix. We found new vessel growth at the edge of the strial explant by the day 3. Branch formation peaks at day 5
( Figures 3A-J) . Significantly more branch formation is seen in the VEGF-A 165 -treated group ( Figure 3L) than in the vehicle-treated group ( Figure 3K) . Intriguingly, the pattern of the newly formed ("de novo") vessels resemble the natural 'mesh pattern' of in situ strial vessels ( Figure 3L , red arrows).
are bar graphs which show significant differences in branch number, branch points, and branch length at day 5 in culture of control and VEGF-A 165 -treated groups (n = 6, **P < 0.01, Student's t-test).
The de novo vessels express tight junction protein
With immunofluorescence labeling, we found that the newly formed vessels expressed tight junction (TJ)
proteins including ZO-1 and occludin, as shown in Figures 4A and 4B . TJ structure between the endothelial cells was also detected under TEM ( Figures 3D and E) . Taken as a whole, the data indicate the new vessels have the semblance of vascular maturity.
The NG2-derived mural cells lead the new vessel growth
A key question in this study was the origin of the new vascular cells. NG2 derived mural cells are wellknown to be essential for vascular morphogenesis during development (Ozerdem et al., 2001b) . In this study, we hypothesized that mural cells, such as the NG2-derived cell lineage, are involved. To determine NG2 + cell involvement, we created NG2 Figure 5C ). GFP fluorescence labeled NG2-derived cells are pronouncedly located at the distal end of sprouts. We confirmed these NG2-derived cells under DIC ( Figure 5C ) and with Alexa Fluor 568 phalloidin labeling for F-actin under low magnification ( Figure 5D ) and high magnification ( Figure 5E ). However, with our techniques we weren't able to resolve whether the progenitors of these tip cells are NG2-derived pericytes or NG2-derived non-pericytes. The data do, however, strongly indicate the tip cells are converted NG2-derived cells, driving new vessel growth in the adult mouse cochlea.
S1P together with VEGF-A165 control sprouting angiogenesis
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In this study, we used a well-established platform to also investigate the role S1P plays in the new strial vessel formation. Our results show, compared to controls ( Figure 6A ), VEGF-A165 facilitates "sprouting angiogenesis", promoting long, thin vessels ( Figure 6B ). By contrast S1P seems to promote proliferation of endothelial cells, seen as an increased level of new branch sprouting ( Figure 6C ). S1P appears to work together with VEGF-A 165 to control vessel shape and size ( Figure 6D) . Figures 5E-G, bar graphs, show branch number, branch points, and branch length on day 5 in culture in control, VEGF-A 165 -treated, S1P, and VEGF-A 165 + S1P-treated groups are significantly different (n = 4, *P < 0.05; **P < 0.01).
Discussion
In this study, we demonstrate new vessels can be generated from adult mouse cochlea with VEGF-A 165 stimulation. Newly formed vessels display ZO-1, occludin, and tight junction structure. We demonstrate for the first time that individual NG2-derived mural cells migrate and the movements drive sprouting angiogenesis in the cochlear stria vascularis. VEGF-A together with S1P signals control vascular growth.
The new findings bring new perspectives on NG2-derived mural cells in the ear. The NG2-derived cells are potential 'regenerative cells' for cochlear vascular engineering applications which might be used to facilitate restoration of hearing when inefficient cochlear blood flow is implicated.
Activation of VEGF-A signaling initiates new vessel generation in adult mouse cochlea
The formation of new blood vessels from existing vessels, angiogenesis, begins in utero and continues into old age (Armulik et al., 2011; Bautch, 2011; Papetti et al., 2002) . Continuous angiogenesis is important for overall tissue and organ health. Functionality in many organ systems has been shown contingent on sufficient blood flow to satisfy metabolic activity (Wilhelm et al., 2016) .
Hair cells are the sensory receptors in the auditory system critical for hearing. Hair cells are extremely vulnerable to hypoxia (Nuttall, 1987) . Inefficient cochlear blood flow often presents in hearing disorders, including in age-related hearing loss, congenital hearing loss, and sudden deafness (Kellerhals, 1972; Neng et al., 2015; Prazma et al., 1990; Schulte et al., 1992) . Recent research has shown a high degree of interplay between damaged neural recovery and vascular regeneration (angiogenesis). Changes in metabolic activity often requires angiogenesis and re-routing or re-establishment of blood flow.
Correspondingly, restoration of sensory hair cells after damage will also require regeneration of vessels.
However, despite the obvious role of the vasculature, angiogenesis in the ear has not been studied, nor has the role of angiogenesis in restoration of hearing been investigated.
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Angiogenesis is regulated by several different signaling pathways (Adams et al., 2007) . Many studies have concluded the central role of VEGF/VEGF-receptor (VEGFR) signaling in angiogenesis, particularly under hypoxic or ischemic conditions (Dzietko et al., 2013; Shimotake et al., 2010) . The VEGF family in mammals comprises four members: VEGF-A, VEGF-B, VEGF-C, and VEGF-D. VEGF-A, a highly conserved secreted glycoprotein, binds its two receptors, Flt-1 and Flk-1. VEGF-A has a wide spectrum of action on cell proliferation, migration, and differentiation in different cell types, all critical for vascular development and restoration (Dzietko et al., 2013; Gerhardt et al., 2003) . In this study, using 
Converted NG2-derived mural cells lead new vessel formation in the cochlea
What mechanisms are involved in this new vessel formation? Angiogenesis depends on a sequence of events involving endothelial cells and pericytes (Armulik et al., 2011) . 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
NG2 mural cells are essential for vascular morphogenesis during development (Armulik et al., 2011; Ozerdem et al., 2001a) , as well as neovascularization in tumors (Huang et al., 2010; Ozerdem et al., 2003) . However, it had not been known that the NG2 derived cells are progenitors of tip cells leading the angiogenesis in the cochlea. Two recent studies reported proliferating NG2 + pericytes implicated in angiogenesis after spinal cord injury and fibrotic scar formation (Hesp et al., 2018) and in vascular formation during embryonic development (Minocha et al., 2015) . Early studies by Bergers and Song (Bergers et al., 2005) demonstrated pericytes migrate ahead of endothelial cells and, by secreting VEGF, guide endothelial sprouting. In recent work, Eilken et al., (2017) has shown the pericytes regulate endothelial sprouting through VEGFR1. In our observation, the NG2 + cells, visualized with phalloidin staining, develop filopodia which directly control new vessel growth. However, our procedures haven't enabled us to identify whether the progenitors of the tip cells are NG2 positive pericytes or NG2 positive non-pericytes. This still needs to be investigated. However, it is clear that cells of NG2-derived linage drive angiogenesis in cochlear angiogenesis.
S1P in synergy with VEGF-A control new vessel size and growth
S1P is a bioactive lipid, acting as intracellular mediator or as ligand of a family of five distinct S1P
receptors (S1Pr1-S1Pr5), a powerful bioactive sphingolipid, involved in the regulation of diverse functions, including cell migration, proliferation and differentiation. The lipid is essential for organ and tissue development and homeostasis (Romero-Guevara et al., 2015) . S1P also acts via specific G proteincoupled receptors to play a critical role in angiogenesis (Hisano et al., 2018) and in blood flow regulation (Scherer et al., 2006; Scherer et al., 2010) . It was recently reported that defect in either S1P transporters or S1P receptors leads to EP loss and non-syndromic hearing loss, with the primary cause abnormal blood vessel development in the stria vascularis (Ingham et al., 2016) . Thus there is considerable interest in determining what role S1P plays in new strial vessel formation. With our well-established angiogenesis model, it was natural to begin investigation of S1P's effect on angiogenesis. We found profound S1P effects on vascular development, including effects on new vessel length and promotion of new vessel growth. Our results corroborate numerous other studies which have shown involvement of S1P signaling in vascular development. S1P defect mouse such as (S1pr1 knockout mice) are embryonic lethal with vascular defects and severe hemorrhaging (Liu et al., 2000) . Researchers have also shown S1P binding its receptor S1Pr increases adherens junction stability and promotes vascular stability. While, in general, VEGF is more prominent as an angiogenic growth factor, regulating both angiogenesis and showing the statistical differences between branch number, branching points, and average branch length.
(n = 4, *P < 0.05; **P < 0.01, Student's t-test).
